Sequus overhauls on the fly

Noteworthy

Senior management changes announced by Sequus Pharmaceuticals Inc. last week are part of an ongoing restructuring that illustrate the difficulties that can arise when a company shifts from a development stage company to an operating entity.

Craig Henderson, chairman and CEO, told BioCentury that he initiated searches in the first quarter for a CFO and for senior management positions in commercial operations and

Read the full 648 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE